Jihye Kim
Jihye Kim
Project Staff, Department of Quantitative Health Sciences, Cleveland Clinic Lerner Research
Verified email at
Cited by
Cited by
DSigDB: drug signatures database for gene set analysis
M Yoo, J Shin, J Kim, KA Ryall, K Lee, S Lee, M Jeon, J Kang, AC Tan
Bioinformatics 31 (18), 3069-3071, 2015
Tankyrase and the Canonical Wnt Pathway Protect Lung Cancer Cells from EGFR InhibitionIdentifying Synthetic Lethal Interactions in Lung Cancer
M Casás-Selves, J Kim, Z Zhang, BA Helfrich, D Gao, CC Porter, ...
Cancer research 72 (16), 4154-4164, 2012
Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid LeukemiaMonocytic AML Is Resistant to Venetoclax
S Pei, DA Pollyea, A Gustafson, BM Stevens, M Minhajuddin, R Fu, ...
Cancer discovery 10 (4), 536-551, 2020
Aging-associated inflammation promotes selection for adaptive oncogenic events in B cell progenitors
CJ Henry, M Casás-Selves, J Kim, V Zaberezhnyy, L Aghili, AE Daniel, ...
The Journal of clinical investigation 125 (12), 4666-4680, 2015
Treating experimental arthritis with the innate immune inhibitor interleukin-37 reduces joint and systemic inflammation
G Cavalli, M Koenders, V Kalabokis, J Kim, AC Tan, C Garlanda, ...
Rheumatology 55 (12), 2220-2229, 2016
Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma
JD Hintzsche, NT Gorden, CM Amato, J Kim, KE Wuensch, SE Robinson, ...
Melanoma research 27 (3), 189, 2017
Regulation of head and neck squamous cancer stem cells by PI3K and SOX2
SB Keysar, PN Le, B Miller, BC Jackson, JR Eagles, C Nieto, J Kim, ...
Journal of the National Cancer Institute 109 (1), djw189, 2017
FGFR1 Expression Levels Predict BGJ398 Sensitivity of FGFR1-Dependent Head and Neck Squamous Cell CancersFGFR1 mRNA Levels Predict Sensitivity to BGJ398 in HNSCC
F Göke, A Franzen, TK Hinz, LA Marek, P Yoon, R Sharma, M Bode, ...
Clinical cancer research 21 (19), 4356-4364, 2015
Integrated genomic analyses identify WEE1 as a critical mediator of cell fate and a novel therapeutic target in acute myeloid leukemia
CC Porter, J Kim, S Fosmire, CM Gearheart, A van Linden, D Baturin, ...
Leukemia 26 (6), 1266-1276, 2012
ATM and MET kinases are synthetic lethal with nongenotoxic activation of p53
KD Sullivan, N Padilla-Just, RE Henry, CC Porter, J Kim, JJ Tentler, ...
Nature chemical biology 8 (7), 646-654, 2012
Rational combination of a MEK inhibitor, selumetinib, and the Wnt/calcium pathway modulator, cyclosporin A, in preclinical models of colorectal cancer
A Spreafico, JJ Tentler, TM Pitts, AC Tan, MA Gregory, JJ Arcaroli, ...
Clinical Cancer Research 19 (15), 4149-4162, 2013
ATM/G6PD-driven redox metabolism promotes FLT3 inhibitor resistance in acute myeloid leukemia
MA Gregory, A D’Alessandro, F Alvarez-Calderon, J Kim, T Nemkov, ...
Proceedings of the National Academy of Sciences 113 (43), E6669-E6678, 2016
Barasertib (AZD1152), a Small Molecule Aurora B Inhibitor, Inhibits the Growth of SCLC Cell Lines In Vitro and In VivoBarasertib Inhibits Small-Cell Lung Cancer Cell Line Growth
BA Helfrich, J Kim, D Gao, DC Chan, Z Zhang, AC Tan, PA Bunn
Molecular cancer therapeutics 15 (10), 2314-2322, 2016
A genetic screen identifies TCF3/E2A and TRIAP1 as pathway-specific regulators of the cellular response to p53 activation
Z Andrysik, J Kim, AC Tan, JM Espinosa
Cell reports 3 (5), 1346-1354, 2013
RIP 1 negatively regulates basal autophagic flux through TFEB to control sensitivity to apoptosis
T Yonekawa, G Gamez, J Kim, AC Tan, J Thorburn, J Gump, A Thorburn, ...
EMBO reports 16 (6), 700-708, 2015
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade
TW Flaig, M Salzmann-Sullivan, LJ Su, Z Zhang, M Joshi, MA Gijón, J Kim, ...
Oncotarget 8 (34), 56051, 2017
TWIST1-induced miR-424 reversibly drives mesenchymal programming while inhibiting tumor initiation
DJ Drasin, AL Guarnieri, D Neelakantan, J Kim, JH Cabrera, CA Wang, ...
Cancer research 75 (9), 1908-1921, 2015
Kinome RNAi Screens Reveal Synergistic Targeting of MTOR and FGFR1 Pathways for Treatment of Lung Cancer and HNSCCFGFR1 and MTOR Coinhibition Synergistically Suppresses Growth
KR Singleton, TK Hinz, EK Kleczko, LA Marek, J Kwak, T Harp, J Kim, ...
Cancer research 75 (20), 4398-4406, 2015
AZ1366: An Inhibitor of Tankyrase and the Canonical Wnt Pathway that Limits the Persistence of Non–Small Cell Lung Cancer Cells Following EGFR InhibitionTankyrase Inhibition …
HA Scarborough, BA Helfrich, M Casás-Selves, AG Schuller, ...
Clinical Cancer Research 23 (6), 1531-1541, 2017
Long term storage of dry versus frozen RNA for next generation molecular studies
E Seelenfreund, WA Robinson, CM Amato, AC Tan, J Kim, SE Robinson
PloS one 9 (11), e111827, 2014
The system can't perform the operation now. Try again later.
Articles 1–20